drugset / Trial / NCT03544944

A Prospective, Randomized, Single-blinded (Evaluator), Parallel, Multi-center, Phase 3 Trial in Bowel Preparation for Colonoscopy

NCT03544944

Phase 3 Completed 297 enrolled Taejoon Pharmaceutical Co., Ltd.
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a prospective randomized study compared with active control arm. The investigators compare the colon cleansing in patients undergoing colonoscopy.

Timeline

Start
2018-01-02
Primary completion
2018-05-30
Completion
2018-07-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Moviprep Other / unclassified
Subject TJP-008-1 Unknown
Subject TJP-008-2 Unknown

Indications

No indication recorded.